Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP-Clinical Excellence | February 22, 2018 | February 26, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date February 22, 2018 · Filed February 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,003 |
Ending reported balance
After 2018-02-25 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2018-02-22 · Grant · Acquired 8,800 · Balance 9,151 F1: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted. Row 2 · 2018-02-22 · Grant · Acquired 300 · Balance 9,451 F2: On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 300 restricted stock units. Row 3 · 2018-02-22 · Tax withholding · Disposed 3,151 · Balance 6,300 Row 4 · 2018-02-25 · Exercise / conversion · Acquired 930 · Balance 7,230 F3: Restricted stock units convert into common stock on a one-for-one basis. Row 5 · 2018-02-25 · Tax withholding · Disposed 227 · Balance 7,003 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $47.97 · Expires 2024-02-05 | Direct | 1,050 |
Reported balance
After 2018-02-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-02-22 · Grant · Acquired 1,050 · Balance 1,050 F4: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,050 stock appreciation rights. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-02-25 | Direct | 930 |
Reported balance
After 2018-02-25 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-02-25 · Exercise / conversion · Disposed 930 · Balance 930 F3: Restricted stock units convert into common stock on a one-for-one basis. F5: On February 25, 2016, the reporting person was granted 1,860 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.
F2: On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 300 restricted stock units.
F3: Restricted stock units convert into common stock on a one-for-one basis.
F4: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,050 stock appreciation rights.
F5: On February 25, 2016, the reporting person was granted 1,860 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · derivative · entry 7 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930 Underlying: Common Stock · 930 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 1,860 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date. Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 227 | $100.84 | $22,890.68 |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 5 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,003 Read SEC document |
| February 25, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 930 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 4 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 1,050 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · derivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Common Stock · 1,050 shares Expires 2024-02-05 F4 · balance_after: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,050 stock appreciation rights. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,151 | $100.54 | $316,801.54 |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,451 F2 · kind: On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the restricted stock units subject to such criteria vested, resulting in the vesting of 300 restricted stock units. Read SEC document |
| February 22, 2018 Filed Feb 26, 2018 19:30 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 8,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013642 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,151 F1 · kind: On February 4, 2015, the reporting person was granted 4,400 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:23 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-008287 · doc4.xml · derivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:23 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 149 | $95.89 | $14,287.61 |
DisclosureSEC source: 0001209191-18-008287 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 20:23 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-008287 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 02, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 5,702 | $102.01 | $581,655.32 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 8 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.00 to $102.041, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 10,000 | $101.50 | $1,015,000.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 7 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT (Spouse, Trustee) Disclosed balance after: 0 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 568.0531 | $103.08 | $58,554.91 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,702 Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 18,300 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 15 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,300 Underlying: Common Stock · 18,300 shares Expires 2028-01-31 F9 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 5,125 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 14 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,125 Underlying: Common Stock · 5,125 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,750 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 13 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 2,750 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,750 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 12 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,400 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 11 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,400 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal year 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 1,700 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 10 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,700 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,125 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · derivative · entry 9 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,125 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 9,937 | $101.16 | $1,005,226.92 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 5 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,270.0531 F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 5,125 | $69.58 | $356,597.50 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 4 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,207.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 2,750 | $68.96 | $189,640.00 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,082.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 3,150 | $47.97 | $151,105.50 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,332.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 19:33 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 3,825 | $37.18 | $142,213.50 |
DisclosureSEC source: 0001209191-18-007219 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,182.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 568.0531 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 14 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F9 · derivative.exercise_date: The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,125 | $0.00 Strike: $21.35 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 13 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,375 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 12 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,375 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F8 · derivative.exercise_date: The option vested in three equal installments at the end of fiscal years 2012, 2013 and 2014 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,375 | $0.00 Strike: $17.33 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 11 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,375 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,184 | $0.00 Strike: $15.91 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 10 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,184 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,892 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 9 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,892 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,505 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · derivative · entry 8 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,505 shares Expires 2019-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested. F4 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 31,956 | $90.00 | $2,876,040.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,357.0531 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 2,500 | $22.10 | $55,250.00 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 5 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,313.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 3,125 | $21.35 | $66,718.75 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 4 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,813.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 18,750 | $17.33 | $324,937.50 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,688.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 1,184 | $15.91 | $18,838.86 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,938.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 21:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 6,397 | $5.98 | $38,267.49 |
DisclosureSEC source: 0001209191-17-023543 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,754.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 1,400 | $0.00 Strike: $47.97 | $0.00 |
DisclosureSEC source: 0001209191-17-014520 · doc4.xml · derivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 1,400 shares Expires 2024-02-05 F4 · balance_after: On February 5, 2014, the reporting person was granted 7,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,400 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 1,700 | $0.00 Strike: $37.18 | $0.00 |
DisclosureSEC source: 0001209191-17-014520 · doc4.xml · derivative · entry 5 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires 2023-02-06 F3 · balance_after: On February 6, 2013, the reporting person was granted 8,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 1,700 stock appreciation rights. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 358 | $85.91 | $30,755.78 |
DisclosureSEC source: 0001209191-17-014520 · doc4.xml · nonDerivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,357.0531 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014520 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,715.0531 F2 · kind: On February 5, 2014, the reporting person was granted 2,000 restricted stock units. The restricted stock units are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the restricted stock units subject to such criteria vested, resulting in the vesting of 400 restricted stock units. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 23:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 451 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014520 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315.0531 F1 · kind: On February 6, 2013, the reporting person was granted 2,250 restricted stock units. The restricted stock units are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2016, 80% of the restricted stock units subject to such criteria vested, resulting in the vesting of 451 restricted stock units. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 00:14 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008459 · doc4.xml · derivative · entry 6 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 564 shares Expires 2023-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 6, 2013, the reporting person was granted 2,250 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 00:14 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 237 | $82.67 | $19,592.79 |
DisclosureSEC source: 0001209191-17-008459 · doc4.xml · nonDerivative · entry 4 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,864.0531 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 00:14 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-008459 · doc4.xml · nonDerivative · entry 3 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,101.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 05, 2017 Filed Feb 8, 2017 00:14 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008459 · doc4.xml · derivative · entry 5 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 500 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 5, 2014, the reporting person was granted 2,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 05, 2017 Filed Feb 8, 2017 00:14 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 210 | $83.80 | $17,598.00 |
DisclosureSEC source: 0001209191-17-008459 · doc4.xml · nonDerivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,537.0531 Read SEC document |
| February 05, 2017 Filed Feb 8, 2017 00:14 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-008459 · doc4.xml · nonDerivative · entry 1 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,747.0531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 01, 2017 Filed Feb 4, 2017 00:26 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 14,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-17-007894 · doc4.xml · derivative · entry 2 Chari Ravi S. · CIK 0001632795 · SVP-Clinical Excellence 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,680 Underlying: Common Stock · 14,680 shares Expires 2027-02-01 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.